Floatz logo

Therapeutic Asset Ratings

6,308 results matching 1 filter

91,564 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Venetoclax
Acquired Polycythemia Vera
M.D. Anderson Cancer CenterP1/2CCC (48)
Venetoclax
Cellular Phase Chronic Idiopathic Myelofibrosis
M.D. Anderson Cancer CenterP1/2CCC (48)
Venetoclax
T-Cell Prolymphocytic Leukemia
Jonsson Comprehensive Cancer CenterP1/2CCC (48)
vg2025
Colorectal Cancer
AkesoP1/2CCC (48)
(+)-Vincristine
EZB-MYC+ Diffuse Large B-Cell Lymphoma
The First Affiliated Hospital with Nanjing Medical UniversityP1/2CCC (48)
(+)-Vincristine
Refractory Precursor T-Lymphoblastic Lymphoma/Leukemia
M.D. Anderson Cancer CenterP1/2CCC (48)
Vincristine Sulfate
Refractory Precursor T-Lymphoblastic Lymphoma/Leukemia
ECOG-ACRIN Cancer Research GroupP1/2CCC (48)
Vitamin D
Drug Allergy
rana alaaeldin aly ibrahim nasrP1/2CCC (48)
Vls-1488
Endometrial Cancer
Volastra Therapeutics, Inc.P1/2CCC (48)
Vls-1488
Ovarian Carcinosarcoma
Volastra Therapeutics, Inc.P1/2CCC (48)
Vls-1488
Squamous Cell Lung Carcinoma
Volastra Therapeutics, Inc.P1/2CCC (48)
Vls-1488
Uterine Carcinosarcoma
Volastra Therapeutics, Inc.P1/2CCC (48)
Vorbipiprant
Digestive System Cancer
Rottapharm BiotechP1/2CCC (48)
Vorbipiprant
Colorectal Cancer
Rottapharm BiotechP1/2CCC (48)
Vorinostat
Acute Leukemia
University of Michigan Rogel Cancer CenterP1/2CCC (48)
White Blood Cells/Granulocytes
Disease Related To Hematopoietic Stem Cell Transplant
University of ManchesterP1/2CCC (48)
wj05129
Cancer
Suzhou Junjing BioSciences Co., Ltd.P1/2CCC (48)
wj13404 tablets
Non-Small Cell Lung Carcinoma
Suzhou Junjing BioSciences Co., Ltd.P1/2CCC (48)
Wve-004
Frontotemporal Dementia
Wave Life Sciences USA, Inc.P1/2CCC (48)
Xanomeline
Schizoaffective Disorder
New York State Psychiatric InstituteP1/2CCC (48)
xnw5004
Metastatic Prostate Carcinoma
Evopoint Biosciences Inc.P1/2CCC (48)
yl-13027
Malignant Pancreatic Neoplasm
Shanghai YingLi Pharmaceutical Co. Ltd.P1/2CCC (48)
Yttrium (90 Y)
Disease Related To Solid Organ Transplantation
University Health Network, TorontoP1/2CCC (48)
Zalifrelimab
Head And Neck Squamous Cell Carcinoma
ImmunoGenesisP1/2CCC (48)
Zelenectide Pavedotin
Ovarian Neoplasm
BicycleTx LimitedP1/2CCC (48)
Showing 2026 to 2050 of 6,308 assets
PreviousPage 82 of 253Next